Machine learning approaches to quantitatively predict selectivity of compounds against hDAC1 and hDAC6 isoforms
Dogan, B.
Show abstract
The design of compounds selectively binding to specific isoforms of histone deacetylases (hDAC) is an ongoing research to prevent adverse side effects. Two of the most studied isoforms are hDAC1 and hDAC6 that are important targets to inhibit in various disease conditions. Here, various machine learning approaches were tested with the aim of developing models to predict the bioactivity and selectivity towards specific isoforms. Selectivity models were developed by directly training on the bioactivity differences of tested compounds against hDAC1 and hDAC6. Both classification and regression models were developed and compared to each other by using traditional evaluation metrics.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-based Classifiers 97%
- Support Vector Machine based prediction models for drug repurposing and designing novel drugs for colorectal cancer 96%
- Discovery of a Novel Non-Narcotic Analgesic Derived from the CL-20 Explosive: Synthesis, Pharmacology and Target Identification of Thio-wurtzine, a Potent Inhibitor of the Opioid Receptors and the Voltage-Dependent Calcium Channels 95%
Similar papers in this journal
- Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation 97%
- Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors 96%
- Identification of Natural Antiviral Drug Candidates Against Tilapia Lake Virus: Computational Drug Design Approaches 95%
Similar papers in this journal
- Discovery of Z1362873773: A Novel Fascin Inhibitor from a Large Chemical Library for Colorectal Cancer 96%
- Mechanistic insights into the Japanese Encephalitis Virus RNA dependent RNA polymerase protein inhibition by bioflavonoids from Azadirachta indica 96%
- PeruNPDB: The Peruvian Natural Products Database for in silico drug screening 95%
Similar papers in this journal
- CHI3L1-Targeted Small Molecules as Glioblastoma Therapies: Virtual Screening-Based Discovery, Biophysical Validation, Pharmacokinetic Profiling, and Evaluation in Glioblastoma Spheroids 95%
- Modulation of endogenous opioid signaling by inhibitors of puromycin sensitive aminopeptidase 95%
- Automated design and optimization of multitarget schizophrenia drug candidates by deep learning 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.